Celltrion said on the 15th that it was selected in the "Top 1%" of the biotechnology institutional sector in the Corporate Sustainability Assessment (CSA) by global credit rating agency S&P Global. This is the only achievement among domestic bio corporations. The company was also named an "Industry Mover," recognized for the scale of its year-over-year improvement in ESG performance.
The CSA is an authoritative index that evaluates ESG across environment, social, and governance for more than 12,000 corporations worldwide and identifies top corporations by industry. The results are reflected in The Sustainability Yearbook, with the top 1%, 5%, and 10% of corporations each selected.
Building on its placement in the top 5% last year, Celltrion entered the top 1% this year, proving its ESG competitiveness among global biotechnology corporations. In particular, it was included as an "Industry Mover," which is given to corporations with the largest score increases, recognizing the company's advancements in ESG management sophistication.
In the environment institutional sector, the company is systematically managing greenhouse gas emissions with a goal of "carbon neutrality by 2045." While promoting a shift to eco-friendly vehicles and expanding the use of renewable energy, it is also applying life cycle assessment (LCA) to 11 biosimilar products to reduce environmental impact.
In the social institutional sector, the company supports startups through open innovation and contributes to building a bio ecosystem. It is using revenue from the in-house bazaar "Celeb Market" to help improve medical environments in developing countries, while continuing social contribution activities such as donating all participation fees raised through the "Dream Run 2026" campaign to the Korea Blood Cancer Association.
On governance, the company introduced a lead independent director system to strengthen board independence. It also paid a cash dividend of 750 won per share last year and carried out a share cancellation of treasury stock worth 895 billion won, recording a shareholder return ratio of 103%, as part of efforts to enhance shareholder value.
A Celltrion official said, "This selection is the result of our ESG management performance and improvement efforts being recognized in the global market," adding, "We will continue activities that contribute to promoting human health and welfare while strengthening the foundation for sustainable growth."